Skip to main content
. 2017 May 18;8(30):49796–49806. doi: 10.18632/oncotarget.17964

Figure 3. Univariate analyses of OS according to the clinicopathologic factors.

Figure 3

(A) No distant metastasis vs. metastatic PanNETs at the time of diagnosis (mean OS 3.0 yrs vs. 16.9 yrs, p < 0.001) (B) Lymph node positive vs. negative at the time of diagnosis (mean OS 8.8 yrs vs. 16.0 yrs, p = 0.025) (C) Whether curative intent surgery was done or not (mean OS 16.7 yrs vs. 2.9 yrs, p < 0.001) (D) WHO grade (mean OS G1 16.4 yrs vs. G2 15.4 yrs vs. G3 0.6 yrs, p < 0.001) and (E) Negative for ATRX/DAXX protein expression (N/Y: mean OS 15.3 yrs vs. 10.8 yrs, p < 0.001) were statistically significant factors associated with OS among the study patients.